Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

NCT06705686 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer (CRPC)
Metastatic Castration-resistant Prostate Carcinoma

Interventions

DRUG: (R)-9bMS

Sponsor

TechnoGenesys, Inc.

Collaborators

[object Object]
[object Object]
[object Object]